Latest in News & Research
Sleep Disturbance Highly Prevalent in Psoriasis Patients
Strongest predictors of sleep impairment include anxiety and depression levels, pruritus exacerbation at night, in morning
Acral Lentiginous Melanoma Survival Varies by Race, SES
Differences in socioeconomic status contribute to survival disparities for Hispanic Black and White patients
Persons With Homelessness Have Higher Odds of Group A Streptococcus SSTIs
However, first-line antibiotic coverage against MRSA more often given to persons experiencing homelessness
Clinical Experts Develop Severity Scale for Alopecia Areata
Scale uses extent of scalp hair loss as primary basis for severity rating and includes four secondary features
Twenty-Nine Novel Loci Identified for Acne Susceptibility
Meta-analysis of genome-wide association studies adds to knowledge of genetic contribution to acne susceptibility
Knowledge of High Skin Cancer Risk Might Modify Risky Behaviors
Those at high risk of skin cancer accurately assessed risk and reported lower likelihood of future tanning bed use
Nivolumab Combo Treats Advanced Esophageal Squamous-Cell Carcinoma
Overall survival longer in patients receiving first-line treatment with nivolumab plus chemo or nivolumab plus ipilimumab versus chemo alone
Which Treatment Is Most Efficacious for Male Androgenetic Alopecia?
Greatest increase in first end point of total hair count at 24 weeks was seen for 0.5 mg/day dutasteride
How Does MMS Compare to Wide Local Excision for cSCC?
Mohs micrographic surgery is less expensive and results in 2.22 weeks of perfect health gained over five years versus WLE
Metastases Occur in About 2 Percent of Cutaneous SCCs
Risk factors for metastases include age, male sex, and immunosuppression
Pfizer Will Ask FDA to Approve Its COVID-19 Vaccine for Children Under 5 Years
If approved, the two-shot regimen would become the first approved for use in children this young
Novel Algorithm May Help Classify Skin Diseases
New algorithm uses multistage fusion process that includes clinical images, dermoscopy images, and patient meta-data
Reporting of Race, Ethnicity Has Improved in Dermatology Trials
However, proportion of reporting articles including at least 20 percent non-White representation unchanged at 38.1 percent
How Does Risankizumab Compare to Fumaric Acid Esters for Plaque Psoriasis?
Significantly more patients achieved ≥90 percent improvement in PASI at week 24 with risankizumab versus FAE
Skyrizi Approved for Psoriatic Arthritis
Approval based on two Phase 3 trials showing more than 50 percent of patients receiving Skyrizi achieved ACR20 response at 24 weeks
Self-Help Aids Quality of Life for People With Psoriasis
Findings show modest, but significant, benefit from either compassion-based or mindfulness-based self-help
Risk for Cancer Increased After VTE for Patients With Psoriasis
Standardized incidence ratio was 3.0 during first year of follow-up after VTE and decreased to 1.5 during subsequent years
Biosimilars Could Cut Spending for Biologic Therapy in the U.S.
Increased market growth of biosimilars that are similar to brand-name biologic agents has the potential to reduce spending on prescription drugs
Recommendations Updated for Recombinant Zoster Vaccine
Recommendations have been updated for use of the recombinant zoster vaccine (RZV) for prevention of herpes zoster and related complications among immunocompromised adults aged...
Is Electrical Impedance Spectroscopy Beneficial for Detecting Melanoma?
EIS increases diagnostic confidence for students and dermatologists assessing lesions clinically suspicious for melanoma
Does Telemedicine Help to Cut Nonattendance for Dermatology Patients?
Telemedicine linked to substantially reduced nonattendance rates in pediatric patients, but not in patients aged 65 years and older
Specialist-Led Model of Care Can Improve CVD Prevention in Psoriasis
Dermatologists and patients with psoriatic disease approve of a specialist-led model of care
FDA Approves Rinvoq for Treatment of Atopic Dermatitis
Approval indicated for those 12 years and older with atopic dermatitis that has not responded to previous treatment
24 of 1292